186 related articles for article (PubMed ID: 8740718)
21. Etoposide in gastric cancer.
Macdonald JS; Havlin KA
Semin Oncol; 1992 Dec; 19(6 Suppl 13):59-62. PubMed ID: 1492227
[TBL] [Abstract][Full Text] [Related]
22. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
[TBL] [Abstract][Full Text] [Related]
23. [Chemotherapy of gastric cancer].
Konishi T; Teruya M; Kawahara M; Itoh A; Asakura R; Araki S; Hojo K; Nouchi T; Takeda Y
Gan To Kagaku Ryoho; 1998 Mar; 25(4):504-15. PubMed ID: 9530356
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy for advanced gastric cancer.
Wagner AD; Grothe W; Behl S; Kleber G; Grothey A; Haerting J; Fleig WE
Cochrane Database Syst Rev; 2005 Apr; (2):CD004064. PubMed ID: 15846694
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of first-line systemic chemotherapy with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil regimens in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective phase II study from South India.
Babu KG; Chaudhuri T; Lakshmaiah KC; Dasappa L; Jacob LA; Babu M; Rudresha AH; Lokesh KN; Rajeev LK
Indian J Cancer; 2017; 54(1):47-51. PubMed ID: 29199662
[TBL] [Abstract][Full Text] [Related]
26. Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial.
Waters JS; Norman A; Cunningham D; Scarffe JH; Webb A; Harper P; Joffe JK; Mackean M; Mansi J; Leahy M; Hill A; Oates J; Rao S; Nicolson M; Hickish T
Br J Cancer; 1999 Apr; 80(1-2):269-72. PubMed ID: 10390007
[TBL] [Abstract][Full Text] [Related]
27. Advances in the therapy of gastric cancer.
Macdonald JS
Gastric Cancer; 2002; 5 Suppl 1():35-40. PubMed ID: 12772886
[TBL] [Abstract][Full Text] [Related]
28. Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, epirubicin and cisplatin (modified ECF) as adjuvant chemotherapy in resected gastric adenocarcinoma.
Unek IT; Unek T; Oztop I; Akman T; Atilla K; Ellidokuz H; Bora S; Sarioglu S; Yilmaz U
Chemotherapy; 2012; 58(3):233-40. PubMed ID: 22832016
[TBL] [Abstract][Full Text] [Related]
29. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
Webb A; Cunningham D; Scarffe JH; Harper P; Norman A; Joffe JK; Hughes M; Mansi J; Findlay M; Hill A; Oates J; Nicolson M; Hickish T; O'Brien M; Iveson T; Watson M; Underhill C; Wardley A; Meehan M
J Clin Oncol; 1997 Jan; 15(1):261-7. PubMed ID: 8996151
[TBL] [Abstract][Full Text] [Related]
30. [Patient with stomach cancer with metastases. What is the value of chemotherapy?].
Wilke H; Stahl M; Vanhoefer U
MMW Fortschr Med; 2003 Nov; 145(48):39-42. PubMed ID: 14724998
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant treatment of gastric cancer.
Macdonald JS; Schnall SF
World J Surg; 1995; 19(2):221-5. PubMed ID: 7754627
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer.
Tsavaris N; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekas D; Tsetis A; Klonaris C
Chemotherapy; 1996; 42(3):220-6. PubMed ID: 8983891
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.
Ryoo BY; Kang YK; Im YH; Kim YJ; Kim BS; Kim TY; Jung SH; Park JH; Baek HJ; Kim YC; Shim YM; Kim CM; Zo JI
Am J Clin Oncol; 1999 Jun; 22(3):253-7. PubMed ID: 10362331
[TBL] [Abstract][Full Text] [Related]
34. [Effectiveness of precautionary chemotherapy in gastric cancer].
Rimassa L; Campagnoli E; Biancofiore G
Tumori; 2000; 86(5 Suppl 2):S5-13. PubMed ID: 11195303
[TBL] [Abstract][Full Text] [Related]
35. A systematic overview of chemotherapy effects in gastric cancer.
Janunger KG; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):309-26. PubMed ID: 11441938
[TBL] [Abstract][Full Text] [Related]
36. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.
Lise M; Nitti D; Marchet A; Sahmoud T; Buyse M; Duez N; Fiorentino M; Dos Santos JG; Labianca R; Rougier P
J Clin Oncol; 1995 Nov; 13(11):2757-63. PubMed ID: 7595735
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy for advanced gastric cancer: across the years for a standard of care.
Scartozzi M; Galizia E; Verdecchia L; Berardi R; Antognoli S; Chiorrini S; Cascinu S
Expert Opin Pharmacother; 2007 Apr; 8(6):797-808. PubMed ID: 17425475
[TBL] [Abstract][Full Text] [Related]
39. Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.
Barone C; Corsi DC; Pozzo C; Cassano A; Fontana T; Noviello MR; Landriscina M; Colloca G; Astone A
Cancer; 1998 Apr; 82(8):1460-7. PubMed ID: 9554521
[TBL] [Abstract][Full Text] [Related]
40. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.
Nitti D; Wils J; Dos Santos JG; Fountzilas G; Conte PF; Sava C; Tres A; Coombes RC; Crivellari D; Marchet A; Sanchez E; Bliss JM; Homewood J; Couvreur ML; Hall E; Baron B; Woods E; Emson M; Van Cutsem E; Lise M; ;
Ann Oncol; 2006 Feb; 17(2):262-9. PubMed ID: 16293676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
